From:
$16.28
Prescription required
Leucovorin Calcium: Uses, Dosage, Side Effects, and More
Reviewed by:
From:
$16.28
Prescription required
Leucovorin calcium is an oral and injectable prescription medication classified as a folate analog and cytoprotective rescue agent, representing the calcium salt of 5-formyltetrahydrofolic acid — an active, reduced form of vitamin B9 (folic acid). It is primarily indicated for leucovorin rescue following high-dose methotrexate chemotherapy, combination treatment of advanced colorectal carcinoma alongside 5-fluorouracil, treatment of megaloblastic anemias, and as a rescue antidote for accidental antifolate overdoses. Because leucovorin is already fully reduced, it bypasses the enzymatic bottlenecks targeted by antifolate chemotherapies, protecting healthy host tissues from rapid cell death. It is available in both oral tablet and intravenous/intramuscular injection formulations, with the route selected based on the required dose volume.
Your Prescription
Ready to Fill
Drug Facts
Generic name
Leucovorin Calcium
Brand names
Wellcovorin
Drug type
Folate Analog; Cytoprotective Rescue Agent
Controlled substance
No
Dosage forms
- Oral conventional tablets (5 mg, 10 mg, 15 mg, 25 mg)
- Intravenous/intramuscular injection — lyophilized powder for reconstitution (50 mg, 100 mg, 200 mg, 350 mg, 500 mg)
Typical dosage
- High-dose methotrexate rescue: 15 mg (approximately 10 mg/m²) orally or IV every 6 hours for a minimum of 10 consecutive doses, initiated within 24 hours of starting the methotrexate infusion; escalate to up to 150 mg IV every 3 hours if delayed clearance or acute kidney injury occurs
- Advanced colorectal carcinoma (with 5-FU): 200 mg/m² IV daily over a minimum of 3 minutes, or 400 mg/m² as a 2-hour infusion, followed immediately by 5-FU.
- Oral doses exceeding 25–50 mg must be replaced with IV due to saturable absorption kinetics.
Basics
What is Leucovorin Calcium?
Leucovorin calcium is an oral and injectable prescription medication classified as a folate analog and cytoprotective rescue agent. It is the calcium salt of 5-formyltetrahydrofolic acid, an active, reduced form of vitamin B9 (folic acid).
Leucovorin calcium is available across solid oral delivery systems and sterile intravenous/intramuscular injection configurations. The physical administration route is chosen based on the absolute dose volume required:
- Oral Conventional Tablet
- Available strengths: 5 mg, 10 mg, 15 mg, 25 mg
- Primary clinical deployment: Low-dose methotrexate rescue schedules, megaloblastic anemia maintenance, and pyrimethamine toxicities
- Controlled status: Non-controlled
- Intravenous / Intramuscular Injection
- Available strengths: 50 mg, 100 mg, 200 mg, 350 mg, 500 mg (lyophilized powder for reconstitution)
- Primary clinical deployment: High-dose methotrexate rescue protocols and advanced colorectal oncology co-infusions
- Controlled status: Non-controlled
Indications
What is Leucovorin Calcium used for?
Clinically, leucovorin calcium is indicated for the:
- Leucovorin Rescue Post High-Dose Methotrexate Therapy: To minimize, mitigate, and prevent severe bone marrow suppression, gastrointestinal mucosal toxicity, and systemic organ failure following high-dose methotrexate chemotherapy in osteosarcoma and alternative malignancies.
- Combination Treatment of Advanced Colorectal Carcinoma: Co-administered alongside intravenous 5-fluorouracil (5-FU) regimens to augment, biochemically potentiate, and extend the overall anti-tumor survival weight of the pyrimidine antagonist.
- Treatment of Megaloblastic Anemias: Managing folate-deficiency anemias secondary to sprue, nutritional deficiencies, pregnancy, infancy, or hepatic disease when oral folic acid therapy is insufficient.
- Prevention and Treatment of Folate Antagonist Toxicities: Serving as an immediate rescue antidote following accidental overdoses of pyrimethamine or trimethoprim.
Because leucovorin provides a direct source of fully reduced folates, it bypasses the structural enzymatic bottlenecks targeted by traditional antifolate chemotherapies, protecting healthy host tissues from rapid cell death.
Mechanism
How does Leucovorin Calcium work?
Pharmacodynamics and Dual Oncological Mechanisms
The molecular biology of leucovorin calcium pivots between protecting healthy host tissues during antifolate therapy and amplifying chemotherapeutic effects during antimetabolite infusions:
Bypassing the Methotrexate Blockade (Host Cytoprotection)
Methotrexate functions as a potent chemotherapeutic agent by binding to and inhibiting the enzyme Dihydrofolate Reductase (DHFR). DHFR is responsible for converting inactive dietary folate into active, fully reduced tetrahydrofolates (FH₄). When DHFR is blocked, healthy cells run completely out of reduced folates, causing a complete arrest of purine and thymidylate synthesis, freezing DNA replication, and triggering massive cellular apoptosis (cell death) in highly proliferative tissues such as bone marrow and gastrointestinal linings.
Leucovorin operates as an immediate shield. Because it is chemically structured as 5-formyltetrahydrofolic acid, it is already fully reduced. It does not require the DHFR enzyme to become biologically functional. Upon administration, it enters healthy cells and converts into active folate pools (FH₄), directly resuming purine and DNA synthesis. This process “rescues” healthy host tissues from methotrexate toxicity.
Biochemical Potentiation of 5-Fluorouracil (Colorectal Oncology)
In colorectal cancer regimens, leucovorin acts conversely to intensify chemotherapy efficacy. 5-Fluorouracil (5-FU) treats tumors by converting to an active metabolite that inhibits the enzyme Thymidylate Synthase (TS), a mandatory step in tumor DNA synthesis. Normally, 5-FU binds to TS loosely and dissociates quickly, allowing the tumor cell to survive.
When leucovorin is infused, it is metabolized to 5,10-methylenetetrahydrofolate. This molecule enters the tumor cell and simultaneously binds to the TS enzyme and 5-FUe, forming an exceptionally stable ternary complex. This locked complex permanently turns off Thymidylate Synthase, resulting in prolonged, intensive inhibition of DNA synthesis and significantly increasing the tumor-killing power of the 5-FU regimen.
Pharmacokinetics
- Absorption and Saturable Kinetics: Following oral administration, leucovorin is absorbed rapidly across the upper gastrointestinal tract; however, the oral route exhibits saturable transport kinetics. At a low dose of 25 mg, the absolute bioavailability is high (~97%). If the oral dose is increased beyond 50 mg, intestinal transport proteins become fully saturated, causing fractional absorption to drop sharply. For rescue doses exceeding 25 mg to 50 mg, oral tablets must be abandoned, and intravenous configurations used exclusively.
- Metabolism and Peak Dynamics: Following oral intake, the parent drug is extensively converted within the intestinal mucosa and liver into its primary active circulating metabolite, 5-methyltetrahydrofolate (5-methyl-FH₄). Peak blood levels (Tmax) of the active metabolite are achieved within 2 hours for tablets and within roughly 1 hour after intravenous infusion.
- Elimination: The apparent terminal elimination half-life of parent leucovorin is short (~45 minutes), whereas the true active 5-methyl-FH₄ metabolite exhibits a prolonged biological half-life of approximately 4 to 6 hours. It is excreted predominantly via renal filtration into the urine as water-soluble folate metabolites.
Dosage
Leucovorin Calcium Dosages & Administration
The High-Dose Methotrexate Rescue Framework
Leucovorin rescue schedules are strictly coordinated protocols based on real-time methotrexate serum tracking:
- The Initialization Timing Mandate: Leucovorin must be initiated precisely within 24 hours of starting the methotrexate infusion. Starting the rescue protocol late (e.g., past 30 to 45 hours) can allow irreversible host bone marrow and mucosal damage to establish, destroying the safety profile of the chemotherapy.
- Standard Rescue Dosing: The standard starting dose is 15 mg (approximately 10 mg/m²) orally or intravenously every 6 hours for a minimum of 10 consecutive doses, or until methotrexate blood levels drop safely below the clearance threshold of 5 × 10⁻⁸ M (0.05 µM).
- Aggressive Dosage Escalation: Methotrexate levels and serum creatinine must be checked daily. If a patient develops acute kidney injury or exhibits delayed methotrexate clearance, the leucovorin rescue dose must be escalated immediately (e.g., up to 150 mg intravenously every 3 hours) and paired with intensive fluid hydration and urinary alkalinization until the narcotic baseline clears.
Colorectal Carcinoma Combination Protocol
Advanced colorectal regimens are administered exclusively intravenously. Multiple oncology frameworks exist, such as infusing leucovorin at 200 mg/m² daily via slow IV injection over at least 3 minutes, or at 400 mg/m² as a 2-hour infusion, always followed immediately by the scheduled 5-fluorouracil injection or continuous infusion block.
Get The Right Dose For Less
Why pay retail prices for the same medication?
At Invictus, we source directly from trusted, FDA-approved manufacturers to keep your costs low without sacrificing quality. Whether you need a one-time fill or regular refills, our transparent pricing makes it easy to save every day.
Side Effects
Leucovorin Calcium Side Effects and Risks
The Intrathecal Methotrexate Absolute Contraindication
Leucovorin calcium is strictly contraindicated for intrathecal (spinal cord fluid) administration. Furthermore, intrathecal leucovorin must never be administered as a rescue agent following intrathecal methotrexate errors.
- The Seizure Emergency: If leucovorin enters the cerebrospinal fluid or directly affects central nervous tissue, its local chemical profile acts as a powerful central neurotoxin, triggering immediate, intractable generalized tonic-clonic seizures, status epilepticus, progressive cerebral edema, and death.
Potentiation of 5-Fluorouracil Toxicities
When paired with 5-FU, leucovorin increases the antimetabolite’s binding weight, which significantly multiplies the frequency and severity of 5-FU-induced toxicities:
- Severe Enteritis and Diarrhea: Enhanced TS blockade can cause profound gastrointestinal mucosal sloughing, leading to severe, intractable, and life-threatening fluid-wasting diarrhea and enterocolitis. Elderly, volume-depleted, or physically frail patients are at extreme risk of circulatory collapse.
- Profound Myelosuppression: Combining these agents escalates the incidence of severe leukopenia, absolute agranulocytosis, and thrombocytopenia, requiring regular Complete Blood Count (CBC) monitoring.
Masking of Vitamin B12 Deficiency (Pernicious Anemia)
Leucovorin can normalize peripheral blood smear markers in patients with undiagnosed pernicious anemia or other vitamin B12 deficiencies by restoring folate-driven erythrocyte maturation.
- The Neurological Trap: While the hematological macrocytic anemia appears corrected on a standard CBC, the underlying vitamin B12 deficiency remains completely untreated and continues to progress. This allows irreversible neurological degeneration—including subacute combined degeneration of the spinal cord, peripheral neuropathies, and permanent cognitive loss—to advance silently. Establish a definitive differential diagnosis between folate and B12 deficiencies before initiating long-term management of macrocytic anemia.
Common Adverse Reactions
Monotherapy (Oral Tablets): Exceptionally rare and well-tolerated. Rare allergic hypersensitivity reactions (urticaria, wheezing, mild pruritus) have occurred. Insomnia or minor psychomotor agitation can manifest at very high doses.
Combination Therapy (With 5-FU):
- Severe nausea, vomiting, stomatitis, and mucositis (painful mouth ulcers)
- Profuse diarrhea and abdominal cramping
- Leukopenia and thrombocytopenia
- Alopecia (hair thinning)
- Palmar-plantar erythrodysesthesia (hand-foot syndrome, presenting as severe redness, peeling, and burning pain on the palms and soles)
Interactions
Leucovorin Calcium Interactions
- Anticonvulsant Medications (Phenobarbital, Phenytoin, Primidone): High-dose exogenous folate administration increases the metabolic clearance and hepatic breakdown of certain anticonvulsants. Co-administration can cause a sharp drop in serum phenytoin or phenobarbital levels, dropping the patient below their therapeutic anti-epileptic threshold and risking a rapid return of breakthrough seizures. Monitor anticonvulsant blood levels closely if leucovorin is added or stopped.
- Standard Oral Fluorouracil Derivatives (Capecitabine): Combining leucovorin with oral capecitabine replicates the 5-FU potentiation pathway, significantly expanding gastrointestinal toxicity weights and diarrhea risks.
- Sulfonamide Antimicrobials (Sulfamethoxazole-Trimethoprim): Leucovorin can compete with or alter the anti-infective mechanics of trimethoprim during active opportunistic infection protocols.
Contraindications
Additional Considerations
Pregnancy and Lactation
- Pregnancy: Leucovorin is an active form of a native B-vitamin (folate) and has not demonstrated an increased risk of structural fetal malformations or embryofetal developmental toxicity. Advanced oncological chemotherapy regimens themselves carry extreme gestational risks. It should be used during pregnancy if maternal oncological or antifolate rescue needs are established.
- Lactation: It is unknown whether leucovorin is excreted directly into human breast milk, though native folates are standard components of milk matrices. It is generally considered compatible with breastfeeding, but the clinical focus must prioritize monitoring the infant if the mother is undergoing active combination chemotherapy regimens due to the profile of the accompanying toxic agents.
Geriatric Care
Older adults aged 65 and over exhibit a significantly higher baseline vulnerability to the severe enteritis and bone marrow suppressive consequences seen during combined leucovorin / 5-fluorouracil oncology infusions. Meticulous tracking of fluid balances, daily stool counts, and CBC parameters is mandatory. Dosage shifts or treatment suspensions must be executed at the first sign of severe stomatitis or diarrhea.
Ready to Start Saving?
No one should overpay for safe, effective medication. By cutting out middlemen and working directly with trusted, FDA-approved manufacturers, Invictus offers the same high-quality medicines you’d find at big retail pharmacies—at a fraction of the price.
Whether you choose brand-name or generic, we’ll deliver it quickly, affordably, and right to your door. Maybe that’s why most patients who switch to Invictus never look back.
Frequently Asked Questions (FAQs)
Didn’t see the answers you’re looking for in this article? Check out this comprehensive FAQ for more details.
Administration & Dosage
Leucovorin calcium tablets should be taken exactly as prescribed by your healthcare provider. Dosing varies depending on the medical condition being treated, including methotrexate rescue therapy, chemotherapy support, or folate deficiency management. The tablets may generally be taken with or without food, but timing is especially important when leucovorin is administered after high-dose methotrexate.
The time it takes for leucovorin to work depends on the reason it is being used. During methotrexate rescue therapy, leucovorin begins helping protect healthy cells within hours after administration. For folate deficiency–related anemia, improvements in blood counts may begin within several days of treatment.
Leucovorin has a relatively short plasma half-life, but its active folate metabolites remain in the body longer as part of normal folate metabolism. Because of this, leucovorin is often given on a carefully timed schedule during methotrexate rescue protocols to maintain protective folate levels.
Patients taking leucovorin should avoid substituting regular folic acid when leucovorin is specifically prescribed for methotrexate rescue or antifolate toxicity. Certain seizure medications, including phenytoin, phenobarbital, and primidone, may also interact with leucovorin and require closer monitoring.
Leucovorin calcium is not available over the counter in the United States. It requires a prescription because it is primarily used in specialized medical settings such as oncology, methotrexate rescue therapy, and management of antifolate toxicity.
Uses & Mechanism of Action
Leucovorin calcium is used for several important medical purposes, including rescue therapy after high-dose methotrexate treatment, enhancement of fluorouracil chemotherapy in colorectal cancer, and treatment of certain folate deficiency conditions. It may also help reduce toxicity from antifolate medications such as pyrimethamine or trimethoprim.
Leucovorin, also called folinic acid, is an active form of folate used in oncology and supportive care medicine. Unlike regular folic acid, leucovorin bypasses specific metabolic steps in the body and can provide active folate directly to cells.
Leucovorin works by supplying active folate that cells can use for DNA synthesis and repair. Methotrexate rescue therapy helps protect healthy cells from antifolate toxicity. In fluorouracil chemotherapy regimens, leucovorin enhances the anticancer activity of fluorouracil by stabilizing its effect on tumor cells.
Leucovorin itself is not considered chemotherapy because it does not directly kill cancer cells. Instead, it is used as a supportive or chemotherapy-modulating medication alongside certain cancer treatments such as methotrexate and fluorouracil.
Leucovorin and folic acid are both forms of folate, but leucovorin is already metabolically active and does not require activation by the enzyme that methotrexate blocks. This difference makes leucovorin effective for methotrexate rescue, while regular folic acid would not provide the same protection in that setting.
Side Effects & Safety
Leucovorin is generally well tolerated, especially compared with many chemotherapy medications. Some individuals may experience mild gastrointestinal symptoms such as nausea, while serious allergic reactions are rare but possible.
Allergic reactions to leucovorin can occur, although they are uncommon. Symptoms may include rash, hives, swelling, dizziness, or difficulty breathing and require immediate medical attention.
Leucovorin may be used during pregnancy when clinically necessary and under medical supervision. Because it is an active form of folate, it may be used in certain specialized clinical situations, including the management of antifolate toxicity.
Leucovorin can improve blood abnormalities caused by vitamin B12 deficiency without correcting the underlying neurological damage. For this reason, leucovorin should not be used as a substitute treatment for pernicious anemia or untreated vitamin B12 deficiency.
Using leucovorin outside established medical indications may increase the risk of medication interactions or inappropriate treatment. In some cases, leucovorin may interfere with seizure medications or mask important nutritional deficiencies, making specialist supervision important during treatment.
Interactions & Contraindications
Leucovorin should not be used in individuals with a known allergy to leucovorin or folinic acid products. It is also not appropriate as a standalone treatment for vitamin B12 deficiency–related anemia because it may mask symptoms while neurological damage continues.
Leucovorin can interact with certain anticonvulsants such as phenytoin, phenobarbital, and primidone, potentially reducing seizure control. It also has important interactions with methotrexate and other antifolate medications, which is why dosing and timing are carefully monitored in oncology settings.
Leucovorin is commonly used in pediatric oncology protocols, including methotrexate rescue therapy for certain childhood cancers. Pediatric dosing is individualized and carefully supervised by specialists.
Leucovorin may reduce the effectiveness of some seizure medications, including phenytoin, phenobarbital, and primidone. Patients taking anticonvulsants may require closer monitoring for seizure control during leucovorin treatment.
Leucovorin is commonly used after high-dose methotrexate therapy as rescue treatment to help protect healthy tissues from toxicity. The timing and dosing schedule are carefully controlled because improper use may reduce treatment effectiveness or fail to prevent toxicity.
Generic & Alternatives
The generic name is leucovorin calcium, which is also known as folinic acid. Generic formulations are widely available in both oral and injectable forms.
Levoleucovorin is the main alternative to leucovorin calcium for methotrexate rescue therapy. It contains the active form of folinic acid and may be used in certain oncology protocols depending on clinical preference and availability.
Leucovorin calcium contains both active and inactive forms of folinic acid, while levoleucovorin contains only the biologically active form. Because of this difference, dosing between the two medications is not interchangeable on a milligram-to-milligram basis.
Leucovorin and folinic acid refer to the same medication. “Leucovorin calcium” is the pharmaceutical name commonly used in clinical practice, while “folinic acid” is the more chemically descriptive term.
Leucovorin calcium is available from multiple generic pharmaceutical manufacturers in the United States. The specific manufacturer may vary depending on the pharmacy, hospital, or oncology center dispensing the medication.
Disclaimer
The information provided on this page is for general informational purposes only and is not intended as medical advice. Always consult with a licensed healthcare provider before starting, stopping, or changing any medication regimen. While Invictus strives to provide accurate and up-to-date information, individual health conditions and circumstances vary. The prices, availability, and descriptions of all medications on this page are subject to change.
Your Prescription
Ready to Fill
